78 / 88
WFSBP 2017
78
Industry Sessions
aa
Monday, 19 June 2017
SA-01 INDUSTRY SPONSORED SATELLITE SYMPOSIUM
13:15–14:45
Auditorium 12
Psychopharmacology in management of schizophrenia:
Recent advances and challenges
(Sunovion)
Chair:
John Kane, USA
001
Findings from scientific trials and clinical reality:
How much progress did we make?
John Kane, USA
002
Managing metabolic outcomes of antipsychotic
treatment: A balancing act with individualised approach
David Taylor, United Kingdom
003
Cognitive and functional outcomes in treatment of
schizophrenia: Current options and future hope
Stein Opjordsmoen, Norway
aa
Tuesday, 20 June 2017
SA-02 INDUSTRY SPONSORED SATELLITE SYMPOSIUM
13:15–14:45
Auditorium 12
Orchestrating the differential diagnosis of organic
psychosis: Shining a spotlight on NP-C
(Actelion)
Chair:
Hans-Hermann Klünemann, Germany
001
Think NP-C: An insidious yet treatable psychiatric
disease
Hans-Hermann Klünemann, Germany
002
Spotting the signs: When does psychosis point
to NP-C?
Oliver Bonnot, France
003
Diagnostic challenges in NP-C: Using the right
tools to make the diagnosis
Christian Hendriksz, United Kingdom
004
Challenging differential diagnoses: Recognising
NP-C in frontotemporal dementia
Alessandro Padovani, Italy
Q&A
Summary and close
Hans-Hermann Klünemann, Germany